Promising Method For Early Diagnosis Of Cancer

Promising Method For Early Diagnosis Of Cancer.
A collaboration of US scientists and own companies are looking into a analysis that could find even one stray cancer room among the billions of cells that circulate in the human bloodstream. The hope is that one day such a test, given soon after a curing is started, could indicate whether the therapy is working or not. It might even indicate beforehand which therapy would be most effective human growth hormone different types. The test relies on circulating tumor cells (CTCs) - cancer cells that have impersonal from the main tumor and are traveling to other parts of the body.

In 2007, researchers at Massachusetts General Hospital, developed a "microfluidic chip," called CellSearch, which could compute the number of waif cancer cells, but that test didn't allow scientists to trap whole cells and analyze them generic. But on Monday, Mass General announced an harmony with Veridex LLC, role of Johnson & Johnson, to study a newer version of the test.

According to the Associated Press, the updated proof requires only a couple of teaspoons of blood. The microchip is dotted with tens of thousands of microscopic posts covered with antibodies designed to stick to tumor cells. As blood passes over the chip, tumor cells withdrawn from the pack and adhere to the posts.